Fatal cases of gabexate mesilate-induced anaphylaxis

International Journal of Clinical Pharmacology Research

Volumn 22, Issue 3-4, 2002, Pages 81-83

  Matsukawa, Y ^a   Nishinarita, S ^a   Sawada, S ^a   Horie, T ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; CONTRAST MEDIUM; CORTICOSTEROID; GABEXATE MESILATE; PROTEINASE INHIBITOR;

ADULT; ANAPHYLAXIS; ARTICLE; ASSISTED VENTILATION; CLINICAL ARTICLE; CONVULSION; CYANOSIS; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG INFUSION; FEMALE; HUMAN; HYPOTENSION; MALE; NAUSEA; PRURITUS; RASH; SHOCK; SURVIVAL; SWEATING; URTICARIA; VASCULAR ACCESS;

ANAPHYLAXIS; FATAL OUTCOME; FEMALE; GABEXATE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; SERINE PROTEINASE INHIBITORS;

EID: 0038038861     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Buchler M., Malfertheiner P., Uhi W., et al. Gabexate mesylate in human acute pancreatitis. Gastroenterology, 104, 1165, 1993.
2. Gavallini G., Tittobello A., Frulloni L., et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N. Engl. J. Med., 335, 919, 1996.
3. Umeki S., Adachi M., Watanabe M., et al. Gabexate as a therapy for disseminated intravascular coagulation. Arch. Intern. Med., 148, 1409, 1988.
4. Novelli G.P., Casali R., Bonizzoli M., et al. Antioxidant action of gabexate mesylate (FOY) in an experimental model of endotoxin shock. Minerva Anestesiol., 61, 509, 1995.
5. Taenaka N., Terada N., Takahashi H., et al. Hemodialysis using gabexate mesylate (FOY) in patients with a high bleeding risk. Crit. Care Med., 14, 481, 1986.
6. Matsukawa Y., Nishinarita S., Horie T., Naruse S. Gabexate mesylate-induced anaphylaxis. Brit. Med. J., 317, 1563, 1998.
7. Matsukawa Y., Nishinarita S., Horie T. Gabexate mesylate-induced anaphylaxis in patients with pancreatitis, but not those with disseminated intravascular coagulation. Clin. Drug Invest., 17, 337, 1999.
8. Fukaya Y. Properness of dripping infusion of gabexate mesylate for a patient having abdominal pain? (In Japanese). JAMIC J., 22, 60, 2002.
9. Erba F., Fiorucci L., Pascarella S., Menegatti E., Ascenzi P., Ascoli F. Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug. Biochem. Phamacol., 61, 271, 2001.